×
Top Dividend Stocks to Buy before the prices go up!
Download Your Free Stock Report!
Our expert team of analysts helps you with Buy, Hold & Sell recommendations!
Our goal is to provide you with best stock market recommendations At the Right Price - At the Right Time
To Get Free Reports Register Now
Register Now
By clicking this button, you agree to our
Terms of Service
and
Privacy Policy
& our Financial Services Guide
(FSG)
×
7 Days Free Trial
Submit
info@aceinvestors.com.au
(02) 9199 9639
Members Login
Contact Us
Home
Research Reports
Daily Recommendations
Dividend Income Report
Growth Stock Report
Speculative Stock Report
US Stock Report
Under 50 cents Special
US Market Report
Segment Specific
Blue Chip
Mid Cap
Small Cap
IPO
Sector Coverage
Banking
Entertainment
Financials
Telecom
Healthcare
Food, Beverage & Tobacco
Insurance
Services and Materials
Technology & IT
IPO
Mining
Energy
Media
Industrial
Utility
Retail
Real Estate
Airlines & Transportation
Consumer Discretionary
Editorial
Sample Report
Subscribe
Healthcare
Home
Healthcare
Driven Brands Holdings Inc. (NASDAQ: DRVN): W...
By ACE Investors / 02 Nov 2023
Read More
Curvebeam AI Limited(ASX: CVB) Potential of A...
By ACE Investors / 26 Oct 2023
Read More
CSL Limited (ASX: CSL): Well Positioned To De...
By ACE Investors / 24 Oct 2023
Read More
Mesoblast Limited(ASX: MSB) Global Leader in ...
By ACE Investors / 24 Oct 2023
Read More
Cogstate Limited (ASX: CGS): Cogstate is well...
By ACE Investors / 23 Oct 2023
Read More
Medibank Private Limited (ASX: MPL): Deliveri...
By ACE Investors / 20 Oct 2023
Read More
Sonic Healthcare Limited (ASX: SHL): Optimall...
By ACE Investors / 18 Oct 2023
Read More
Mayne Pharma Group Ltd (ASX: MYX): The sale o...
By ACE Investors / 18 Oct 2023
Read More
Capitol Health Limited (ASX: CAJ): CAJ Delive...
By ACE Investors / 17 Oct 2023
Read More
Radiopharm Theranostics Limited – Significa...
By ACE Investors / 16 Oct 2023
Read More
BCAL Diagnostics Limited(ASX: BDX) Consistent...
By ACE Investors / 13 Oct 2023
Read More
Paradigm Biopharmaceuticals Ltd (ASX: PAR): i...
By ACE Investors / 13 Oct 2023
Read More
‹ First
<Previous
12
13
14
15
16
Next >
Last ›
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2024 ACE Investors. All Right Reserved. Design by
Ace Investors